Medtronic Officer Files Form 144 to Sell $1.0M in Common Shares Under 10b5-1 Plan

Executive Summary

On October 15, 2026, Michael Marinaro, an Officer at Medtronic plc (MDT), submitted a Form 144 filing declaring an intent to sell 10,420 shares of common stock through Fidelity Brokerage Services LLC. The estimated market value of the proposed disposition is $1,000,320.00, representing an implied share price of $96.00.

Transaction & Plan Highlights

• Trading Plan: The proposed sale is executed pursuant to a Rule 10b5-1 trading plan adopted on March 17, 2026, adhering to cooling-off and scheduled trading practices.
• Origin of Shares: The securities scheduled for liquidation were acquired between 2019 and 2025 across multiple equity compensation channels:
  • Restricted stock vesting grants (totaling over 7,400 shares)
  • Employee Stock Purchase Plan (ESPP) purchases
  • Dividend reinvestment allocations
  • Stock option exercise (272 shares on January 27, 2025)
• Past Sales: The filer reported no other share sales in the preceding three months.

Market Impact & Significance

This filing carries Low market significance. With approximately 1.28 billion shares outstanding, the proposed 10,420-share transaction represents less than 0.001% of total float. Furthermore, execution under a pre-established Rule 10b5-1 trading plan reflects routine programmatic portfolio rebalancing and compensation liquidity rather than discretionary insider sentiment.